Aclaris Therapeutics (ACRS) Stock Chart & Stock Price History $1.57 +0.06 (+3.97%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$1.57 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aclaris Therapeutics Stock Price Performance The Aclaris Therapeutics (ACRS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 36.52%, with a year-to-date return of -36.69%. In the past month, the stock has increased 25.60%, reflecting recent market activity. As of the latest close, Aclaris Therapeutics traded at $1.57 with a market cap of $170.00 million and volume of 846,103 shares. Five years ago, the stock traded at $1.41, representing a 11.35% increase over that period. At the time, it had a market cap of $62.81 million and a volume of 441,400 shares. Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.61%1 Month Performance+25.60%3 Month Performance-1.26%Year-To-Date Performance-36.69%1 Year Performance+36.52%5 Year Performance+11.35% ACRS Stock Chart for Thursday, June, 12, 2025 ACRS Chart by TradingView Aclaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$1.51$1.57+3.97%$1.59$1.48846,103 shs$170.00 million06/10/2025$1.49$1.51+1.34%$1.55$1.45298,956 shs$163.50 million06/09/2025$1.53$1.49-2.61%$1.55$1.47786,877 shs$161.34 million06/06/2025$1.56$1.53-1.92%$1.65$1.53736,933 shs$165.67 million06/05/2025$1.61$1.56-3.11%$1.63$1.54636,635 shs$168.92 million06/04/2025$1.47$1.61+9.52%$1.65$1.471.69 million shs$174.33 million06/03/2025$1.44$1.47+2.08%$1.51$1.42427,651 shs$159.17 million06/02/2025$1.45$1.44-0.69%$1.53$1.42645,432 shs$155.93 million05/30/2025$1.46$1.45-0.68%$1.48$1.39750,839 shs$157.01 million05/29/2025$1.41$1.46+3.55%$1.46$1.38792,273 shs$158.09 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$1.27$1.41+11.02%$1.56$1.352.81 million shs$152.68 million05/27/2025$1.26$1.27+0.79%$1.34$1.27623,976 shs$137.52 million05/26/2025$1.26$1.26$1.29$1.22404,328 shs$136.43 million05/23/2025$1.26$1.26$1.29$1.22404,328 shs$136.43 million05/22/2025$1.29$1.26-2.33%$1.31$1.25462,350 shs$139.68 million05/21/2025$1.35$1.29-4.44%$1.38$1.27640,661 shs$139.68 million05/20/2025$1.30$1.35+3.85%$1.38$1.28487,036 shs$146.18 million05/19/2025$1.31$1.30-0.76%$1.34$1.28530,970 shs$140.77 million05/16/2025$1.22$1.31+7.38%$1.32$1.18491,151 shs$141.85 million05/15/2025$1.18$1.22+3.39%$1.24$1.16532,769 shs$132.10 million05/14/2025$1.22$1.18-3.28%$1.25$1.16478,418 shs$127.77 million05/13/2025$1.25$1.22-2.40%$1.27$1.22413,298 shs$132.10 million05/12/2025$1.26$1.25-0.79%$1.35$1.24430,838 shs$135.35 million Related Companies Sana Biotechnology Stock Chart Trevi Therapeutics Stock Chart Bicara Therapeutics Stock Chart Autolus Therapeutics Stock Chart Evolus Stock Chart Phathom Pharmaceuticals Stock Chart ChromaDex Stock Chart Stoke Therapeutics Stock Chart Upstream Bio Stock Chart Taysha Gene Therapies Stock Chart Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRS) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
